UK markets open in 4 hours 54 minutes
NIKKEI 225
38,470.40 -364.70 (-0.94%) HANG SENG
18,568.86 +89.49 (+0.48%) CRUDE OIL
78.06 -0.32 (-0.41%) GOLD FUTURES
2,316.80 -7.40 (-0.32%) DOW
38,884.26 +31.99 (+0.08%) Bitcoin GBP
50,191.01 -936.27 (-1.83%)
Anebulo Pharmaceuticals, Inc. (ANEB)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous close | 2.9500 |
| Open | 3.1100 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 3.0400 - 3.1800 |
| 52-week range | 1.6200 - 4.0500 |
| Volume | |
| Avg. volume | 5,890 |
| Market cap | 78.837M |
| Beta (5Y monthly) | -1.00 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.4100 |
| Earnings date | 09 May 2024 - 13 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 6.00 |
Simply Wall St.We Think Anebulo Pharmaceuticals (NASDAQ:ANEB) Needs To Drive Business Growth Carefully
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Business WireAnebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2024 Financial Results and Recent Updates
AUSTIN, Texas, February 13, 2024--Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2024 Financial Results and Recent Updates
Business WireAnebulo Pharmaceuticals Reports First Quarter Fiscal Year 2024 Financial Results and Recent Updates
AUSTIN, Texas, November 14, 2023--Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2024 Financial Results and Recent Updates
© 2024 Yahoo. All rights reserved.